CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $112,595 | -48.7% | 67,021 | -13.7% | 0.00% | – |
Q2 2023 | $219,659 | -28.5% | 77,618 | +24.1% | 0.00% | – |
Q1 2023 | $307,062 | +118.1% | 62,538 | +377.1% | 0.00% | – |
Q4 2022 | $140,791 | -100.0% | 13,109 | -62.8% | 0.00% | -100.0% |
Q3 2022 | $329,640,000 | +58.6% | 35,218 | +54.7% | 0.00% | – |
Q2 2022 | $207,799,000 | -48.4% | 22,760 | -31.3% | 0.00% | -100.0% |
Q1 2022 | $402,554,000 | -9.0% | 33,132 | -8.8% | 0.00% | 0.0% |
Q4 2021 | $442,378,000 | -48.4% | 36,320 | -34.6% | 0.00% | 0.0% |
Q3 2021 | $857,614,000 | +90.8% | 55,509 | +76.2% | 0.00% | 0.0% |
Q2 2021 | $449,562,000 | +26.5% | 31,504 | +92.5% | 0.00% | 0.0% |
Q1 2021 | $355,262,000 | +81.6% | 16,364 | +26.6% | 0.00% | – |
Q4 2020 | $195,586,000 | +60.7% | 12,927 | +35.1% | 0.00% | – |
Q3 2020 | $121,740,000 | +382.3% | 9,567 | +548.2% | 0.00% | – |
Q2 2020 | $25,240,000 | -84.6% | 1,476 | -88.1% | 0.00% | – |
Q1 2020 | $163,527,000 | +115.4% | 12,379 | +162.7% | 0.00% | – |
Q4 2019 | $75,910,000 | -30.3% | 4,712 | -20.9% | 0.00% | – |
Q3 2019 | $108,857,000 | +39.2% | 5,955 | +63.7% | 0.00% | – |
Q2 2019 | $78,196,000 | -41.2% | 3,637 | -46.3% | 0.00% | – |
Q1 2019 | $132,984,000 | +102195.4% | 6,778 | +67680.0% | 0.00% | – |
Q4 2018 | $130,000 | -99.4% | 10 | -98.9% | 0.00% | – |
Q3 2018 | $21,124,000 | +14.3% | 882 | -8.6% | 0.00% | – |
Q2 2018 | $18,480,000 | -73.8% | 965 | -83.1% | 0.00% | – |
Q1 2018 | $70,541,000 | +4.8% | 5,698 | +3.6% | 0.00% | – |
Q4 2017 | $67,296,000 | +114.2% | 5,498 | +139.6% | 0.00% | – |
Q3 2017 | $31,419,000 | -16.7% | 2,295 | -6.4% | 0.00% | – |
Q2 2017 | $37,721,000 | +9213.8% | 2,451 | +11040.9% | 0.00% | – |
Q1 2017 | $405,000 | -72.6% | 22 | -86.2% | 0.00% | – |
Q4 2016 | $1,477,000 | -87.2% | 159 | -88.5% | 0.00% | – |
Q3 2016 | $11,573,000 | +205.0% | 1,386 | +75.7% | 0.00% | – |
Q2 2016 | $3,795,000 | -94.1% | 789 | -79.5% | 0.00% | – |
Q4 2015 | $64,742,000 | +13.3% | 3,840 | -4.0% | 0.00% | – |
Q3 2015 | $57,131,000 | +238.5% | 3,998 | +187.8% | 0.00% | – |
Q2 2015 | $16,876,000 | +1162.2% | 1,389 | +944.4% | 0.00% | – |
Q1 2015 | $1,337,000 | +34.0% | 133 | +11.8% | 0.00% | – |
Q3 2014 | $998,000 | -80.2% | 119 | -59.8% | 0.00% | – |
Q2 2014 | $5,038,000 | – | 296 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |